Navigation Links
Compounds Identified That Might Treat Nerve Diseases
Date:1/19/2010

Researchers aim to 'chaperone' proteins involved in diseases like Parkinson's

TUESDAY, Jan. 19 (HealthDay News) -- Researchers report that they've developed a new way to find compounds that could become treatments for degenerative nerve disorders such as Alzheimer's, Huntington's and Parkinson's diseases.

The diseases cause proteins in nerve cells known as neurons to "misfold." In the new research, scientists say they've found molecules that play a role in the body's efforts to "chaperone" the molecules that fix the broken proteins.

The scientists studied one of the molecules and used rat neurons to show that it does indeed serve as a protective chaperone. Research in fruit flies showed the same thing.

Researchers say the study could lead to treatments that manipulate the chaperone molecules, leading to repair of the broken proteins.

"We found a creative way to identify new molecules that can activate the body's natural protein-folding machinery," senior author Dennis J. Thiele, professor of pharmacology and cancer biology at Duke University Medical Center in Durham, N.C., said in a news release.

The research appeared in the Jan. 19 online issue of PLoS Biology.

More information

The U.S. National Institute of Neurological Disorders and Stroke has more on Parkinson's disease.



-- Randy Dotinga



SOURCE: Duke University, news release, Jan. 19, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Prenatal exposure to flame-retardant compounds affects neurodevelopment of young children
2. Marijuana Compounds Could Beat Back Brain Cancer
3. Spice Compounds May Stem Tumor Growth
4. Amylin Pharmaceuticals and Takeda Enter into Worldwide Agreement to Co-Develop and Commercialize Compounds for Obesity
5. Study shows how to boost value of Alzheimers-fighting compounds
6. New class of compounds discovered for potential Alzheimers disease drug
7. Novel light-sensitive compounds show promise for cancer therapy
8. Neuromed Announces that Merck & Co., Inc. Terminates Research Collaboration and License Agreement for Compounds Targeting N-Type Calcium Channels
9. Research Findings on Nine GlaxoSmithKline Cancer Compounds to be Presented at ASCO 2009
10. Newly Identified Compounds May Inhibit Strep Infection
11. PRA SPEAKING EVENT: Phase I Studies with Hepatitis C Compounds in Healthy Volunteers and Patients: Views from Inside
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... 18, 2017 , ... “Prompted By Love”: a love story thrown into doubt ... Nettles. Author Mary P. Nettles has devoted her life to ministry since the ... lifelong desire to write was, however, not fulfilled until 2014 when "The Color of ...
(Date:8/18/2017)... ... ... “Case #10-5411 Veterans Administration”: a personal account of corruption ... Administration” is the creation of published author, Carol Mulhern, single mother of two ... work at the Coatesville VAMC as a file clerk then later became the ...
(Date:8/17/2017)... ... August 17, 2017 , ... Shared leadership between ... extremely effective, very effective, or effective by 85% of respondents, according to the ... Insights Reports are based on surveys of the NEJM Catalyst Insights Council, a ...
(Date:8/17/2017)... ... August 17, 2017 , ... When Amy Cowperthwait left the ... took with her a dream to make nursing education more relevant and prepare aspiring ... skills were integrated into healthcare provider education. , “The human element was ...
(Date:8/17/2017)... ... August 17, 2017 , ... CARF ... three years for its residential drug and alcohol detox program. This accreditation decision ... and shows the organization’s substantial conformance to the CARF standards. , Behavioral health ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)...  AOTI Inc. announced today that its fully owned ... a New York City Office in Yonkers, New York ... Wound Oxygen (TWO 2 ) homecare therapy. This new East Coast ... Care (ACHC) under the company,s DMEPOS accreditation for Home/Durable Medical Equipment ... Advanced Oxygen Therapy ...
(Date:8/8/2017)... --   Second-quarter 2017 revenues ... per share from continuing operations ... percent to $110 million ... $161 million Second-quarter 2017 ... increased 8 percent to $0.93 ...
(Date:8/7/2017)...  Endo International plc (NASDAQ: ENDP ) ... all known U.S. mesh product liability claims and that ... remaining U.S. claims at reasonable values. Under the agreements, ... quarter of 2017 and continuing through the fourth quarter ... results, the Company intends to increase its mesh product ...
Breaking Medicine Technology: